Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Tender ID
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
Refer Docs
Bid Security (EMD)
Refer Docs
Closing Date
7 Dec 2026, 23:59 (+05:30)7 Dec 2026, 11:59 pm IST
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Announcement 10 November 2026: the Set 1 of Q&A document is now available under "Documents" tab. Announcement 03 November 2026: The submission deadline of the tender extended from 16 November 2026, 23:59 hours, Jamnagar time ( IST = GMT+5:30) to 07 December 2026, 23:59 hours, Jamnagar time ( IST = GMT+5:30) The deadlines submitting an intention to bid and clarification requests are extended to 27 November 2026; 18:00 hours, Jamnagar time ( IST = GMT+5:30) The purpose of this Request for Proposals (RFP) is to enter into a contractual agreement with a successful contractor or consortium to develop the Phase 1 preliminary TCIM Research Methods-and-Evidence Architecture and the Preliminary TCIM Research Navigator (Early Alpha Test Product). See detailed Terms of Reference and bidding instructions under “Documents” below. Please note: it is NOT necessary to click on “Express Interest” on the top right-hand side of the screen. In order to inform WHO that you are interested in participating in this Request for Proposals, please follow the provisions of the RFP document below.
317935
WHO-SHQ-GTMC-RFP-26-2035
Request for proposal
Afghanistan, Albania, Algeria, American Samoa, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, British Indian Ocean Territory, Brunei, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cabo Verde, Cayman Islands, Central African Republic, Chad, Chile, China, Christmas Island, Colombia, Comoros, Republic of the Congo, Cook Islands, Costa Rica, Côte d’Ivoire, Croatia, Cuba, Cyprus, Czechia, Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Timor-Leste, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Falkland Islands, Faroe Islands, Fiji, Finland, France, French Guiana, French Polynesia, Gabon, Gambia, Georgia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, North Korea, South Korea, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macao, North Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn Islands, Poland, Portugal, Puerto Rico, Qatar, Réunion, Romania, Russia, Rwanda, Saint Helena, Saint Kitts and Nevis, Saint Lucia, Saint Pierre and Miquelon, Saint Vincent and the Grenadines, Samoa, San Marino, São Tomé and Príncipe, Saudi Arabia, Senegal, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Svalbard and Jan Mayen, Eswatini, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Thailand, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Türkiye, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, Tanzania, United States, Uruguay, Uzbekistan, Vanuatu, Venezuela, Vietnam, British Virgin Islands, United States Virgin Islands, Wallis and Futuna, Western Sahara, Yemen, Zambia, Zimbabwe, Antarctica, Palestine, Serbia, Montenegro, Kosovo, South Sudan
RFP
+05:30
21 Nov 2026
13 Oct 2026
Date: 10-Nov-26
ANSWERS TO REQUESTS FOR CLARIFICATIONS FROM BIDDERS
Request for Proposals (Ref. N°.): WHO-SHQ-GTMC-RFP-26-2035
COLOR CODING: If this is the second or subsequent set of answers to bidders questions for this RFP, the previous Q&As can still be found below, and are not highlighted. The new answers to Bidders questions are highlighted in Yellow. Pending answers are highlighted in light grey. If already published answers have been modified, are highlighed in red color.
N°. RFP Section Reference Question Answer from WHO
31 Would a 20-minute discussion be possible at your convenience? WHO is unable to hold an individual discussion with a prospective bidder during the RFP period. Clarification requests must be submitted through the formal written process, and responses of general relevance will be included in the consolidated clarification communicated to prospective bidders.
30 Our team is currently preparing the proposal materials and would appreciate confirmation of eligibility and any further instructions. WHO cannot provide an advance determination of a prospective bidder's eligibility. Eligibility and responsiveness will be determined against the requirements of the RFP. Any additional instructions or amendments applicable to the solicitation will be communicated through the formal procurement process.
28 Section 4.10 In accordance with Section 4.10, we sincerely request that WHO consider extending the RFP to BUCM. As per item 3.2.1. Status of the RFP document (page 7) the Contractor shall be a for profit or not for profit institution operating in the field of health research methods, evidence assessment, traditional, complementary and integrative medicine, and digital knowledge or decision-support product development. This condition allows BUCM to submit a proposal and all other non-for profit organization that complies with the rest of the conditions outlined in this item and other parts of the RFP.
27 Beijing University of Chinese Medicine (BUCM) respectfully requests confirmation of its eligibility to participate in RFP No. WHO-SHQ-GTMC-RFP-26-2035. WHO cannot pre-qualify or confirm the eligibility of an individual prospective bidder through the clarification process. Eligibility and responsiveness will be determined in accordance with the requirements of the RFP and the proposal submitted.
26 Please also confirm the current deadline and the deadline/channel for formal questions. The proposal submission deadline is 07 December 2026 at 23:59 hours, Jamnagar time (IST = GMT+5:30). The deadline for clarification requests and intention-to-bid submissions is 27 November 2026 at 18:00 hours, Jamnagar time (IST = GMT+5:30). Formal questions should be submitted through the official channel stated in the solicitation, quoting Bid Ref. WHO-SHQ-GTMC-RFP-26-2035.
25 Please identify any required travel, local registration, specialist TCIM/research credentials, minimum corporate experience, consortium or subcontracting conditions, insurance and submission requirements. The assignment is primarily remote with regular virtual WHO coordination, and the RFP does not prescribe routine mandatory travel for Phase 1. Bidders should identify and cost any travel they consider necessary.
24 Could you confirm whether a US-based company may participate and whether the complete scope may be delivered remotely? The RFP does not establish a nationality restriction limiting participation to entities established in a particular country. The assignment is primarily remote with regular virtual WHO coordination.
23 Please provide the current RFP, annexes and any amendments, or the correct public access route. The current solicitation documents, annexes and published updates are available through the official UNGM notice for RFP WHO-SHQ-GTMC-RFP-26-2035. Any further formal amendment will be communicated through the official procurement channel. https://www.ungm.org/Public/Notice/317935
22 Tool scope: for the early-alpha Navigator, is a searchable evidence map with LLM-assisted study tagging and human review in line with what WHO expects? A searchable evidence map may be proposed only insofar as it supports the required Phase 1 products. The Phase 1 solution must use curated, source-grounded content and explicit configurable rules, must not use user-facing AI, and must comply with the bounded alpha requirements. Bidders should not assume that LLM-assisted tagging is permitted unless confirmed by WHO through the formal clarification process.
21 Eligibility: can an India-based sole proprietor take part as a consortium member or subcontractor? The RFP requires the Contractor to be an eligible institution and permits consortium and subcontracting arrangements. The RFP does not expressly specify the eligibility of a sole proprietor as a consortium member or subcontractor.
20 Consortium: may a consortium be led by a research partner, with an independent software engineer delivering the Research Navigator tool? The lead organization may be either a research or TCIM-focused institution or an information technology/digital solutions company. The RFP does not require the consortium to be led exclusively by a traditional medicine technical or research organization. In either case, the lead organization must meet the applicable institutional requirements, demonstrate the capacity to manage and deliver the complete Phase 1 requirement, and ensure that the consortium collectively provides all required research, TCIM, evidence, digital product and technical expertise. The proposal must clearly disclose all consortium members and subcontractors and define their respective roles and responsibilities. The lead organization will remain fully responsible and accountable for the entire contract, including the work of consortium members and subcontractors, and WHO will deal only with the lead organization for contractual, administrative, technical and financial matters.
19 Whether there is a formal process for communicating interest in this limited scope to prospective lead bidders, without submitting a proposal for the entire RFP. Interested parties are responsible for establishing their own consortium or subcontracting arrangements. Communications concerning the RFP must follow the formal process specified in the solicitation.
18 Whether an independent research practice based in Japan would be eligible to deliver such a component remotely. The assignment is primarily remote, with regular virtual coordination with WHO. An entity based in Japan may be proposed as part of an eligible consortium or subcontracting arrangement, subject to all applicable requirements of the RFP. Eligibility of an individual or sole-proprietor practice should not be assumed unless confirmed by WHO.
17 Whether a specialist documentary verification component could be included through a subcontractor or consortium member under this RFP. Yes. Bidders may structure the team using consortium members and/or disclosed subcontractors, provided the proposal covers the complete requirement and clearly identifies the roles, responsibilities and relevant information concerning all participating organizations and personnel. All proposed personnel remain subject to the applicable RFP requirements and WHO approval provisions.
16 Where development requires access to external databases, evidence resources, or subscription-based services that are not provided by WHO, should bidders include the associated licensing/subscription costs in their financial proposal, or would these resources be provided or funded separately by WHO? The bidder is responsible for identifying, obtaining and funding all external databases, evidence resources, software, licences, subscriptions and other technical resources required to deliver the proposed solution, unless the RFP expressly states that a resource will be provided by WHO. All such costs must be transparently identified and included in the financial proposal, together with any relevant assumptions or dependencies.
15 If AI-based functionality is proposed, should bidders include all anticipated model/API, agent, hosting, and ongoing usage costs within their financial proposal? The financial proposal must provide the total project price and required breakdown. All software, licences, applications, tools, hosting and other technical resources necessary for the proposed solution must be identified and fully costed. Any proposed solution must also comply with the RFP requirements and restrictions concerning AI functionality.
14 Could WHO please clarify whether the Phase 1 solution is expected to operate entirely through curated content and explicit configurable rules, without any AI functionality, or whether non-user-facing AI may be used to support development or operation of the solution? The Phase 1 alpha must use curated, source-grounded content and explicit configurable rules and must not use user-facing AI. Any proposed use of non-user-facing AI during development or operation must not alter these requirements and should not be assumed to be permitted unless confirmed by WHO through the formal clarification process.
13 We understand that English will be the starting point, it is planned that the Navigator will support other languages as well? The minimum Phase 1 alpha scope is English-language. Phase 1 does not require implementation of additional languages. Bidders may design the architecture in a manner that facilitates possible future expansion, but any Phase 2 expansion is outside this RFP and would require separate procurement and WHO approval.
12 Could WHO please confirm whether bidders must propose the complete Phase 1 requirement, or whether proposals for individual components will be considered? Proposals must cover the complete Phase 1 requirement. proposals offering only part of the requirement may be rejected. Bidders may use an eligible consortium or subcontracting structure to bring together the capabilities needed to deliver the complete requirement.
11 Where priority countries or regions are identified, will WHO facilitate access to relevant country-level data sources, knowledge resources, partnerships, or subject-matter experts required for the project? The contractor will be responsible for securing and managing the expertise, data sources, knowledge resources and partnerships necessary to perform the assignment. Bidders should describe how their proposed team and expert network will meet these requirements. Where appropriate and feasible, WHO may explore opportunities to facilitate relevant introductions or access to WHO-held resources, but bidders should not make their proposal dependent on such support unless it is expressly agreed by WHO.
10 Priority Member States: Are there particular Member States, regions, or country contexts that will serve as the starting point for this project? No specific priority Member States or regions are prescribed
9 Institutional Requirements: Could WHO clarify what is meant by an ‘institution’ in the RFP? Is WHO seeking organizations with a particular institutional profile, such as universities or research institutions, or are consulting/research firms equally eligible provided they demonstrate the required capabilities and experience? For this RFP, the contractor may be a for-profit or not-for-profit institution operating in the relevant fields specified in Section 3.2.1. The RFP does not restrict eligibility to universities or academic research institutions. Consulting or research firms may participate provided they satisfy the applicable requirements and evaluation criteria.
8 May the Digital Product and Technical Lead be provided by a subcontractor to the lead organization rather than by a consortium member, and if so, is the subcontractor assessed under Institutional and Consortium Experience or only within the technical proposal? The Digital Product and Technical Lead may be provided through a consortium member or a disclosed subcontracting arrangement, provided the proposed individual meets the applicable RFP requirements. The lead organization will remain fully responsible and accountable for the performance of the entire contract, including all work performed by consortium members and subcontractors. The lead organization must clearly disclose all consortium members and subcontractors in the proposal, define their respective roles and responsibilities, and describe the arrangements for coordinating, supervising and managing their performance. WHO will deal only with the lead organization for all contractual, administrative, technical and financial matters. The proposed personnel and organizational arrangements will be assessed against the applicable published evaluation criteria
7 Section 4.2 Where a proposal is submitted by a consortium under a lead organization, is the Intention to Bid requirement in section 4.2 met by the lead organization alone, or is each consortium member expected to have returned Annex 1, Annex 2 and Annex 6 separately by the 25 October date? For a joint proposal, the proposal is submitted in the name of one consortium member acting as the lead organization and main point of contact with WHO. The requirement is concerning submission of Annexes 1, 2 and 6 by the lead organization
6 Should the alpha cover both primary and secondary research methods, or only one of these? The RFP does not specify that the alpha must be limited to either primary or secondary research methods. Bidders should propose the research-method families they consider appropriate for the priority research-question types and explain the rationale for their proposed scope. The final alpha scope will be subject to WHO review and approval during inception.
5 Can you please clarify which research domains are of interest for the project: preclinical research (including requirements for good manufacturing practices GMP), clinical research (e.g., case reports, noninterventional studies, experimental studies, epidemiology, diagnostic studies etc.), health systems research (e.g., health services, economics, policy), or health sociology research (e.g., ethnomedicine, surveys and qualitative research about TCIM use) The architecture is intended to support multidisciplinary health-research methods relevant to the selected Phase 1 research questions and TCIM systems or practice archetypes. The RFP identifies questions including effectiveness, safety, diagnosis, mechanisms, lived experience, implementation and health-system integration. For comparability of proposals, the alpha must cover 4-6 priority research-question types and 4-6 established research-method families. The specific Phase 1 selection will be proposed by the contractor and approved by WHO during inception.
4 Can you please confirm wheter deadlines for project milestones can be flexible to account for delays during the project development? Bidders should prepare proposals on the basis of the D1-D6 milestones specified in the RFP and should include appropriate contingency time and risk-mitigation arrangements. Any subsequent modification to contractual milestones would require WHO's prior written agreement and would be governed by the final contractual arrangements.
3 Can you please clarify whether the evidence-assessment routing should minimally characterize the established methods (in terms of purpose, inputs, alternatives and uncertainty) and direct the user to relevant external guidance and sources, or if this product should encompass the full description and use of the established method guidance? The Phase 1 requirement is to route users to relevant established evidence-assessment approaches, explain their purpose, inputs and limitations, and identify areas where no validated approach is available. The product is not expected to reproduce or replace the full external guidance for those established approaches.
2 Section 3.3.1 Can you please clarify the definition and scope of the pathways required for the alpha scope in section 3.3.1? Are these patwhays defined by a combination of a research-question type, a research-method family, a chosen TCIM system or practice archetype, and an evidence type? For Phase 1, a complete worked pathway means an end-to-end application of the Navigator logic across an agreed research question and TCIM system or practice archetype. It should include characterization, consideration of potentially appropriate established research methods and alternatives, supporting sources and uncertainty, generation of an editable Method Appropriateness Statement, and routing to relevant evidence-assessment approaches. The precise combination of users, questions, systems or archetypes, methods and evidence types will be proposed by the contractor and agreed with WHO during inception.
1 Due to unforeseen factors affecting the workflow, we kindly request an extension of 15 days for the submission of the proposal. This additional time will help ensure the highest quality and alignment with requirements. WHO has extended the proposal submission deadline to 07 December 2026 at 23:59 hours, Jamnagar time (IST = GMT+5:30). The deadlines for submitting an intention to bid and clarification requests have also been extended to 27 November 2026 at 18:00 hours, Jamnagar time (IST = GMT+5:30), as published on UNGM.
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
WHO-SHQ-GTMC-RFP-26-2035_PUBL_20261013.docx
Bidding document • 0.81 MB
Q&A WHO-SHQ-GTMC-RFP-26-2035_SET_1_101126.xlsx
Bidding document • 0.02 MB
Notice on UNGM.html
Notice page • 0.02 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .